These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16202337)

  • 21. Review of clinical trials using early acute intervention with oral triptans for migraine management.
    Dowson AJ; Mathew NT; Pascual J
    Int J Clin Pract; 2006 Jun; 60(6):698-706. PubMed ID: 16805756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.
    Gori S; Morelli N; Acuto G; Caiola F; Iudice A; Murri L
    Minerva Med; 2006 Dec; 97(6):467-77. PubMed ID: 17213783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing.
    Brandes JL; Kudrow D; Cady R; Tiseo PJ; Sun W; Sikes CR
    Cephalalgia; 2005 Sep; 25(9):735-42. PubMed ID: 16109056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zolmitriptan (Zomig).
    Rapoport AM; Bigal ME; Tepper SJ; Sheftell FD
    Expert Rev Neurother; 2004 Jan; 4(1):33-41. PubMed ID: 15853613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of oral triptans for acute migraine: mixed treatment comparison.
    Asseburg C; Peura P; Oksanen T; Turunen J; Purmonen T; Martikainen J
    Int J Technol Assess Health Care; 2012 Oct; 28(4):382-9. PubMed ID: 23013610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Management costs of chest and CNS-related adverse events associated with the treatment of acute migraine attacks with oral triptans].
    Slof J; Badia X; Lainez-Andres JM; Galvan J; Heras J
    Neurologia; 2005; 20(6):290-8. PubMed ID: 16007512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eletriptan in migraine.
    Diener HC
    Expert Rev Neurother; 2005 Jan; 5(1):43-53. PubMed ID: 15853473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients].
    Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M
    Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management.
    Goadsby PJ; Dodick DW; Ferrari MD; McCrory DC; Williams P
    Acta Neurol Scand; 2004 Sep; 110(3):137-43. PubMed ID: 15285768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans.
    Ng-Mak DS; Hu XH; Chen Y; Ma L; Solomon G
    Int J Clin Pract; 2007 Jul; 61(7):1091-111. PubMed ID: 17537184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral almotriptan: practical uses in the acute treatment of migraine.
    Dowson AJ
    Expert Rev Neurother; 2004 May; 4(3):339-48. PubMed ID: 15853532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Triptans versus other migraine medicine--secondary publication].
    Tfelt-Hansen P
    Ugeskr Laeger; 2009 Apr; 171(18):1485-7. PubMed ID: 19425262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptans: actions and reactions.
    Nahas SJ; Silberstein SD
    Headache; 2008 Apr; 48(4):611-3. PubMed ID: 18377383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review.
    Lipton RB; Bigal ME; Goadsby PJ
    Cephalalgia; 2004 May; 24(5):321-32. PubMed ID: 15096220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Almotriptan: meeting today's needs in acute migraine treatment.
    Láinez MJ
    Expert Rev Neurother; 2007 Dec; 7(12):1659-73. PubMed ID: 18052762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eletriptan: a review and new perspectives.
    Sandrini G; Perrotta A; Nappi G
    Expert Rev Neurother; 2006 Oct; 6(10):1413-21. PubMed ID: 17078782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.
    Mullins CD; Weis KA; Perfetto EM; Subedi PR; Healey PJ
    J Manag Care Pharm; 2005 Jun; 11(5):394-402. PubMed ID: 15934798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spotlight on eletriptan in migraine.
    McCormack PL; Keating GM
    CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are the triptans for migraine therapy worth the cost?
    Becker WJ
    Can J Neurol Sci; 2000 May; 27(2):111-5. PubMed ID: 10830342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.